Matthew V N OSullivan
Overview
Explore the profile of Matthew V N OSullivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1055
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shaban R, Li C, OSullivan M, Kok J, Dempsey K, Ramsperger M, et al.
J Sci Med Sport
. 2020 Dec;
24(6):520-525.
PMID: 33303369
Objectives: Skin and soft tissue infections commonly affect athletes and can lead to cluster outbreaks if not managed appropriately. We report the findings of an investigation into an outbreak of...
12.
Dotel R, OSullivan M, Gilroy N, Sivagnanam S, Davis J
Intern Med J
. 2020 Nov;
50(11):1437-1438.
PMID: 33215827
No abstract available.
13.
Shaban R, Li C, OSullivan M, Gerrard J, Stuart R, Teh J, et al.
Intern Med J
. 2020 Nov;
51(1):42-51.
PMID: 33196128
Background: On 31 December 2019, the World Health Organization recognised clusters of pneumonia-like cases due to a novel coronavirus disease (COVID-19). COVID-19 became a pandemic 71 days later. Aim: To...
14.
Robosa R, Sandaradura I, Dwyer D, OSullivan M
Pathology
. 2020 Oct;
52(7):783-789.
PMID: 33039095
The aim of this study was to assess the analytic and clinical performance of four rapid lateral flow point-of-care tests (POCTs) for identifying SARS-CoV-2-specific antibodies. A retrospective study was conducted...
15.
Hueston L, Kok J, Guibone A, McDonald D, Hone G, Goodwin J, et al.
Open Forum Infect Dis
. 2020 Sep;
7(9):ofaa387.
PMID: 32989419
Background: Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies has become an important tool, complementing nucleic acid tests (NATs) for diagnosis and for determining the prevalence of coronavirus...
16.
Shaban R, Nahidi S, Sotomayor-Castillo C, Li C, Gilroy N, OSullivan M, et al.
Am J Infect Control
. 2020 Sep;
48(12):1445-1450.
PMID: 32890549
Background: Isolation and quarantine are key measures in outbreak management and disease control. They are, however, associated with negative patient experiences and outcomes, including an adverse impact on mental health...
17.
Macartney K, Quinn H, Pillsbury A, Koirala A, Deng L, Winkler N, et al.
Lancet Child Adolesc Health
. 2020 Aug;
4(11):807-816.
PMID: 32758454
Background: School closures have occurred globally during the COVID-19 pandemic. However, empiric data on transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among children and in educational settings are...
18.
Tong S, Lye D, Yahav D, Sud A, Owen Robinson J, Nelson J, et al.
JAMA
. 2020 Feb;
323(6):527-537.
PMID: 32044943
Importance: Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with mortality of more than 20%. Combining standard therapy with a β-lactam antibiotic has been associated with reduced mortality, although adequately powered...
19.
Steinig E, Duchene S, Robinson D, Monecke S, Yokoyama M, Laabei M, et al.
mBio
. 2019 Nov;
10(6).
PMID: 31772058
The evolution and global transmission of antimicrobial resistance have been well documented for Gram-negative bacteria and health care-associated epidemic pathogens, often emerging from regions with heavy antimicrobial use. However, the...
20.
Dotel R, Tong S, Bowen A, Nelson J, OSullivan M, Campbell A, et al.
Trials
. 2019 Jun;
20(1):353.
PMID: 31196132
Background: Exotoxins are important virulence factors in Staphylococcus aureus. Clindamycin, a protein synthesis inhibitor antibiotic, is thought to limit exotoxin production and improve outcomes in severe S. aureus infections. However,...